FDA Inspection 880057 — Osmotica Pharmaceutical Corporation

Osmotica Pharmaceutical Corporation — FEI 3005371242

The FDA completed an inspection of Osmotica Pharmaceutical Corporation on May 7, 2014 in Wilmington, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
May 7, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Wilmington, NC (United States)

Additional details

Postmarket Adverse Drug Experience (PADE)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.